Insmed (INSM) Revenue (2010 - 2026)

Insmed's Revenue history runs 12 years deep, the most recent figure standing at $306.0 million for Q1 2026.

• On a quarterly basis, Revenue rose 229.62% year-over-year to $306.0 million in Q1 2026; TTM through Mar 2026 was $819.6 million, a 115.09% increase from a year earlier, with the FY2025 full-year figure at $606.4 million, up 66.73% from the prior year.
• Revenue climbed to $306.0 million in Q1 2026 per INSM's latest filing, from $263.8 million in the prior quarter.
• Across five years, Revenue topped out at $306.0 million in Q1 2026 and bottomed at $53.1 million in Q1 2022.
• The 5-year median for Revenue is $83.7 million (2023), against an average of $107.5 million.
• Across the five-year window, Revenue advanced 5.66% in 2022 and surged 229.62% in 2026, its largest moves.
• Year by year, Revenue stood at $59.3 million in 2022, then soared by 41.13% to $83.7 million in 2023, then climbed by 24.79% to $104.4 million in 2024, then surged by 152.62% to $263.8 million in 2025, then increased by 15.96% to $306.0 million in 2026.
• Per Business Quant, the three latest INSM Revenue figures stand at $306.0 million (Q1 2026), $263.8 million (Q4 2025), and $142.3 million (Q3 2025).